ChemicalBook >> CAS DataBase List >>PF-06700841 tosylate

PF-06700841 tosylate

CAS No.
1883299-62-4
Chemical Name:
PF-06700841 tosylate
Synonyms
PF841;PF 841;PF-841;CS-2861;PF6700841;PF 6700841;PF-6700841;PF-06700841 tosylate;Brepocitinib (PF-06700841);inhibit,Janus kinase,PF06700841,JAK,Brepocitinib,Inhibitor,PF 06700841
CBNumber:
CB94674167
Molecular Formula:
C18H21F2N7O
Molecular Weight:
389.4
MDL Number:
MFCD31813694
MOL File:
1883299-62-4.mol
Last updated:2024-05-28 11:51:27

PF-06700841 tosylate Properties

Boiling point 637.1±65.0 °C(Predicted)
Density 1.63±0.1 g/cm3(Predicted)
storage temp. room temp
solubility DMSO: 78 mg/mL (200.31 mM);Ethanol: 78 mg/mL (200.31 mM)
form powder
pka 7.28±0.10(Predicted)
color white to beige
Water Solubility Water: Insoluble
FDA UNII 3X8387Q25N

PF-06700841 tosylate price More Price(7)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich PZ0345 PF-06700841 tosylate salt ≥98% (HPLC) 1883299-62-4 5mg $114 2024-03-01 Buy
Biorbyt Ltd orb573132 PF-06700841 tosylate >98% 1883299-62-4 100mg $1283.5 2021-12-16 Buy
Biorbyt Ltd orb573132 PF-06700841 tosylate >98% 1883299-62-4 250mg $2245.7 2021-12-16 Buy
Biorbyt Ltd orb573132 PF-06700841 tosylate >98% 1883299-62-4 1g $4766.8 2021-12-16 Buy
DC Chemicals DC12489 PF-06700841freebase >98% 1883299-62-4 1g $3200 2021-12-16 Buy
Product number Packaging Price Buy
PZ0345 5mg $114 Buy
orb573132 100mg $1283.5 Buy
orb573132 250mg $2245.7 Buy
orb573132 1g $4766.8 Buy
DC12489 1g $3200 Buy

PF-06700841 tosylate Chemical Properties,Uses,Production

Chemical Properties

The p-toluenesulfonic acid salt of brepocitinib exhibits good aqueous solubility (4.84 mg/mL at pH 7.64; >7 mg/mL in simulated gastric fluids). This compound also displayed high passive membrane permeability (mean PAPP = 18.8 × 10?6 cm/s as determined using Ralph Russ canine kidney cells (RRCK)).

Characteristics

Class: non-receptor tyrosine kinase
Treatment: immunological disorders
Other name: PF-06700841; Brepocitinib
Elimination half-life = 3.8–7.5 h
Protein binding = 39%

Uses

PF-06700841 tosylate salt has been used as an inhibitor of Janus kinase1 (JAK1) to study its therapeutic effect on the adjuvant induced arthritis (AIA) rat model. It has also been used as an inhibitor of interferon-α/β receptor alpha chain (IFNAR1) signaling adaptor tyrosine kinase (2TYK2) in mice.

Biochem/physiol Actions

PF-06700841 prevents IL-23 (interleukin 23) signaling through TYK2 (Tyrosine-protein kinase 2)/JAK1 (Janus kinase 1) inhibition.

Pharmacokinetics

The high oral bioavailability of brepocitinib obtained from rats (83%) is consistent with its high passive permeability and good solubility. The elimination half-life of brepocitinib ranged from 3.8 to 7.5 h after a single oral dose and from 4.9 to 10.7 h after multiple-dose administration. It was eliminated from the body by CYP450-mediated hepatic metabolism (84%) (mainly via CYP3A4) and renal clearance (16%). Oxidation of the N-methyl pyrazole (2) is the major metabolic pathway, followed by N-demethylation (3) and N-dealkylation with loss of pyrazole (4).
PF-06700841 tosylate

PF-06700841 tosylate Preparation Products And Raw materials

Raw materials

Preparation Products

PF-06700841 tosylate Suppliers

Global( 68)Suppliers
Supplier Tel Email Country ProdList Advantage
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32686 60
Jinan Carbotang Biotech Co.,Ltd.
+8615866703830 figo.gao@foxmail.com China 7154 58
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
+86-021-61551413 +8618813727289 contact@trustwe.com China 5738 58
Career Henan Chemica Co
+86-0371-86658258 15093356674; laboratory@coreychem.com China 30255 58
NINGBOBENKANGJS PHARMTECHCO., LTD
+8615990591583 15990591583 CHINA 2029 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6313 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471 sales@sarms4muscle.com China 10523 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6393 58
LEAP CHEM CO., LTD.
+86-852-30606658 market18@leapchem.com China 24738 58
Nantong HI-FUTURE Biology Co., Ltd.
+undefined18051384581 sales@chemhifuture.com China 3136 58
PF-06700841 tosylate ((S)-2,2-difluorocyclopropyl)(3-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone PF 6700841 PF-06700841; PF 06700841; PF06700841; PF-6700841; PF 6700841; PF6700841; PF-06700841 TOSYLATE SALT PF6700841 PF-6700841 CS-2861 ((S)-2,2-difluorocyclopropyl)((1R,5S)-3-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone Methanone, [(1S)-2,2-difluorocyclopropyl][3-[2-[(1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]-3,8-diazabicyclo[3.2.1]oct-8-yl]- Brepocitinib (PF-06700841) inhibit,Janus kinase,PF06700841,JAK,Brepocitinib,Inhibitor,PF 06700841 PF 841 PF841 PF-841 1883299-62-4 C18H21F2N7O api APIS